Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 3Phase 1/2 1

Status

Completed 4

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Genitourinary 3Gynecologic 2Breast 2Other hematologic neoplasm 1

Conditions

Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Kidney Neoplasms 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Leukemia 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 95Biopsy 79Magnetic Resonance Spectroscopy 74Paclitaxel 56Cyclophosphamide 53Cisplatin 53Radiotherapy 51Carboplatin 50Gemcitabine 43Bortezomib 38Irinotecan 37Taxes 32Fluorouracil 32Radiation 30veliparib 29Filgrastim 29Doxorubicin 29Vorinostat 27Oxaliplatin 27Leucovorin 27Ipilimumab 27alvocidib 26Cytarabine 26Temozolomide 25aldesleukin 24Rituximab 24fludarabine 23Etoposide 23Decitabine 23temsirolimus 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × NIH × valspodar × Clear all
NCT00002912 2013-02-01

Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00001302 2008-03-04

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
80 enrolled
BreastGenitourinaryGynecologicLymphoid

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Neoplasm Metastasis, Ovarian Neoplasms

NCT00001383 2008-03-04

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
52 enrolled
BreastGenitourinaryGynecologicLymphoid

Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, Neoplasms, Ovarian Neoplasms

NCT00001570 2008-03-04

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
46 enrolled
Genitourinary

Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡